$IMDX 3 SEC Filings

Filed On	Filing
27 Dec 2024	Form 3: Smith Patrick W, 10% owner Holds 1,683,684 shares of Common Stock, no par value
24 Jun 2024	Form 3: James Andrea S., Chief Financial Officer No securities owned
09 Dec 2022	Form 3: Silverman Lou, Director Holds 6,270 shares of Common Stock, no par value
09 Dec 2022	Form 3: Riggs Josh, Interim CEO Holds 2,308 shares of Common Stock, no par value
22 Sep 2022	Form 3: Liu James Yang, Controller, PAO
08 Aug 2022	Form 3: Gutfreund John Peter, Director Holds 3,085,047 shares of Common Stock, no par value
13 Jun 2022	Form 3: John Anish M., SVP, Finance, and Interim CFO
14 Oct 2021	Form 3: Paulsen Gisela, Chief Operating Officer
24 May 2021	Form 3: Yu Li, VP Cntrllr/Prncpl Acctng Offcr
28 Jan 2021	Form 3: Pura Vida INVESTMENTS, Llc, 10% owner and 1 other Holds 12,223,953 shares of Common Stock, No Par Value
31 Aug 2020	Form 3: Carter Jennifer L., Director
02 Apr 2020	Form 3: Ross Douglas T., Chief Medical Officer
22 Aug 2019	Form 3: Kalajian Tony T, SVP-Chief Accounting Officer
26 Jul 2019	Form 3: Griffith Melinda, Director
03 Jun 2019	Form 3: Sundar Padma, SVP, Marketing & Market Access
16 Aug 2018	Form 3: Parker Albert P, Chief Operating Officer
12 Apr 2018	Form 3: Andrews Ronald Asbury, Director
17 Nov 2017	Form 3: Levine Mitchell S, Chief Financial Officer No securities owned
14 Nov 2016	Form 3: Hesterberg Lyndal K., Sr VP, Research & Development
08 Sep 2016	Form 3: Broadwood Partners Lp, 10% owner and 2 others Holds 2,631,681 shares of Common Stock, no par value

Comments